endo health solutions inc
(ENDP:NASDAQ GS)

Executive Profile*

Background*

Mr. Rajiv De Silva has been the Chief Executive Officer and President of Endo Health Solutions Inc., since March 2013. Mr. De Silva served as the President at Valeant Pharmaceuticals International, Inc. from October 2010 to January 15,2013 and served as its Chief Operating Officer until January 15,2013. He was responsible for all specialty pharmaceutical operations, including sales and marketing, research and development, manufacturing and business development. He ... has broad international experience, having worked in the United States, Europe, Canada and Latin America. Mr. De Silva served as the Chief Operating Officer of Specialty Pharmaceuticals at Valeant Pharmaceuticals International from January 5, 2009 to September 2010. He was responsible for overseeing the U.S., Canadian and Australian specialty pharmaceuticals operations. Prior to joining Valeant in January 2009, held various leadership positions with Novartis AG from 2003 to 2009. He served as President of Novartis Vaccines USA and Head, Vaccines of the Americas at Novartis since 2007. During which time, he played a key leadership role at Novartis' Vaccines & Diagnostics Division. From 2005 to 2007, he served as President of Novartis Pharmaceuticals Canada and also served as its Chief Executive Officer. He originally joined Novartis as Global Head of Strategic Planning for Novartis Pharma AG in Basel, Switzerland in 2003. Prior to his time at Novartis, Mr. De Silva served as a Partner at McKinsey & Company and served as its Principal, where he focused his consulting practice on the pharmaceutical industry. During his nine years at McKinsey, he led multiple efforts related to pharmaceutical strategy, sales and marketing, research and development operations, organization design, and mergers and acquisitions. He has been a Director of Endo Health Solutions Inc., since March 2013; and Afexa Life Sciences Inc. since October 2011. He served as a Director of AMAG Pharmaceuticals Inc., from February 2012 to May 23, 2013. Mr. De Silva holds a Bachelor of Science in civil engineering, Honors from Princeton University, a Master of Science in civil engineering from Stanford University and a Master of Business Administration with Distinction from the Wharton School at the University of Pennsylvania.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
ENDP:US	$38.82 USD	-0.48

COMPETITOR COMPENSATION